| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Gilead Sciences, Inc.: Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024 | 281 | Business Wire | Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease -
Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research... ► Artikel lesen | |
| Di | Gilead Sciences Hosts Inaugural Global Health Equity Summit | 289 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Driven by our purpose to make the world a healthier place for all people, we've worked to improve health equity and advance equitable access to care. Last... ► Artikel lesen | |
| 14.05. | Gilead Sciences, Inc.: Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy | 504 | Business Wire | - Analysis Comparing Real-World and Clinical Trial Data Show Yescarta Has Higher Manufacturing Success Rates and Improved T-Cell Performance, Respectively, in Second-Line vs. Third-Line+ Treatment... ► Artikel lesen | |
| 14.05. | Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care | 279 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research when her father was diagnosed with non-Hodgkin lymphoma. The devastating news put her work... ► Artikel lesen | |
| 10.05. | Decoding Gilead Sciences' Options Activity: What's the Big Picture? | 20 | Benzinga.com | ||
| 09.05. | GILEAD SCIENCES, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 09.05. | Gilead Sciences: Gilead's FOCUS Program Helps Zero In on Early HIV Detection | 615 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon. But when... ► Artikel lesen | |
| 09.05. | Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? | 25 | Forbes | ||
| 08.05. | GILEAD SCIENCES, INC. - 10-Q, Quarterly Report | 13 | SEC Filings | ||
| 08.05. | Gilead Sciences appoints Peter Wickersham to vice-president and general manager in the UK and Ireland | 6 | PMLiVE | ||
| 07.05. | Gilead Sciences: Gilead Helps Put African Nation on Path To Eliminate Hepatitis C | 332 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 7, 2024 / James had been free from using drugs for a decade when a routine test at his local health center revealed he had hepatitis C (HCV).James was one of many... ► Artikel lesen | |
| 06.05. | Gilead Sciences Unusual Options Activity For May 06 | 12 | Benzinga.com | ||
| 06.05. | How Is The Market Feeling About Gilead Sciences? | 22 | Benzinga.com | ||
| 03.05. | Gilead Sciences: Forbes Has Listed Gilead as One of America's Best Employers for Diversity | 485 | ACCESSWIRE | NORTHAMPTON, MA / ACCESSWIRE / May 3, 2024 / Gilead SciencesForbes has listed Gilead as one of America's Best Employers for Diversity. We believe that by championing inclusion and diversity, we not... ► Artikel lesen | |
| 03.05. | Gilead Sciences Aktie: Biotechstrukturen im Wandel | 545 | Boersia.de | Die vergangene Woche war für den Biotech-Sektor besonders ereignisreich: Übernahmen und Gewinnberichte führten zu starken Veränderungen. Im Fokus standen die Ergebnisse von Gilead Sciences und GSK plc... ► Artikel lesen | |
| 30.04. | Gilead Sciences Aktie: Zukunft unter Beobachtung | 602 | Boersia.de | Gilead Sciences (GILD) steht in den Schlagzeilen, da Zacks.com die Aktie des HIV- und Hepatitis-C-Medikamentenherstellers zu den meistgesuchten Werten zählt. Die Aktien des Unternehmens verzeichnen... ► Artikel lesen | |
| 30.04. | Gilead Sciences Aktie: Kurskorrektur voraus? | 745 | Boersia.de | In den letzten Wochen geriet die Aktie von Gilead Sciences, einem bedeutenden Hersteller von HIV- und Hepatitis-C-Medikamenten, in das Blickfeld der Investoren. Aufgrund verschiedener Faktoren verzeichnete... ► Artikel lesen | |
| 27.04. | Gilead Sciences Aktie: Umsatzwachstum trotz Verlust | 818 | Boersia.de | Gilead Sciences, ein Biopharmazieunternehmen, hat im ersten Quartal trotz eines schmaleren als erwarteten Verlusts und über den Schätzungen liegenden Umsätzen Fortschritte gemacht. Im Vergleich zum... ► Artikel lesen | |
| 26.04. | Gilead Sciences Unusual Options Activity | 15 | Benzinga.com | ||
| 26.04. | Gilead Sciences declares $0.77 dividend | 43 | Seeking Alpha |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 8.171 |
| NEL | 5.474 |
| EVOTEC | 4.652 |
| TUI | 2.611 |
| PLUG POWER | 2.367 |
| BAYER | 2.042 |
| SUPER MICRO COMPUTER | 2.042 |
| GAMESTOP | 1.993 |
| BIONTECH | 1.915 |
| RHEINMETALL | 1.538 |
| VOLKSWAGEN | 1.253 |
| JINKOSOLAR | 1.166 |
| DEUTSCHE LUFTHANSA | 1.141 |
| DEUTSCHE BANK | 1.122 |
| BYD | 1.098 |
| AIXTRON SE | 1.075 |
| SIEMENS ENERGY | 1.055 |
| TESLA | 1.029 |
| COMMERZBANK | 959 |
| MERCEDES-BENZ | 945 |
| RENK GROUP | 915 |
| THYSSENKRUPP | 879 |
| INFINEON | 852 |
| CUREVAC | 814 |
| BASF | 811 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
